BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22986744)

  • 21. Modeling medulloblastoma in vivo and with human cerebellar organoids.
    Ballabio C; Anderle M; Gianesello M; Lago C; Miele E; Cardano M; Aiello G; Piazza S; Caron D; Gianno F; Ciolfi A; Pedace L; Mastronuzzi A; Tartaglia M; Locatelli F; Ferretti E; Giangaspero F; Tiberi L
    Nat Commun; 2020 Jan; 11(1):583. PubMed ID: 31996670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
    Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
    J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer.
    Agoston Z; Schulte D
    Development; 2009 Oct; 136(19):3311-22. PubMed ID: 19736326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth.
    Tatard VM; Xiang C; Biegel JA; Dahmane N
    Cancer Res; 2010 Feb; 70(3):1236-46. PubMed ID: 20103640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review.
    Blake C; Widmeyer K; DAquila K; Mochizuki A; Smolarek TA; Pillay-Smiley N; Kim SY
    Am J Med Genet A; 2024 Jul; 194(7):e63604. PubMed ID: 38511879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OTX1 and OTX2 Genes in Medulloblastoma.
    Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK
    World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
    Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
    Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
    Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
    Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
    Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
    Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The homeobox gene Otx2 in development and disease.
    Beby F; Lamonerie T
    Exp Eye Res; 2013 Jun; 111():9-16. PubMed ID: 23523800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTCF promotes muscle differentiation by modulating the activity of myogenic regulatory factors.
    Delgado-Olguín P; Brand-Arzamendi K; Scott IC; Jungblut B; Stainier DY; Bruneau BG; Recillas-Targa F
    J Biol Chem; 2011 Apr; 286(14):12483-94. PubMed ID: 21288905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.
    Fuller GN; Su X; Price RE; Cohen ZR; Lang FF; Sawaya R; Majumder S
    Mol Cancer Ther; 2005 Mar; 4(3):343-9. PubMed ID: 15767543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray discovery of new OGT substrates: the medulloblastoma oncogene OTX2 is O-GlcNAcylated.
    Ortiz-Meoz RF; Merbl Y; Kirschner MW; Walker S
    J Am Chem Soc; 2014 Apr; 136(13):4845-8. PubMed ID: 24580054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medulloblastoma with focal divergent/teratoid differentiation.
    Majumdar K; Tyagi I; Saran RK; Sakhuja P; Sharma A
    Brain Tumor Pathol; 2013 Jan; 30(1):50-6. PubMed ID: 22615000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
    Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
    Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of human rhombic lip differentiation underlies medulloblastoma formation.
    Hendrikse LD; Haldipur P; Saulnier O; Millman J; Sjoboen AH; Erickson AW; Ong W; Gordon V; Coudière-Morrison L; Mercier AL; Shokouhian M; Suárez RA; Ly M; Borlase S; Scott DS; Vladoiu MC; Farooq H; Sirbu O; Nakashima T; Nambu S; Funakoshi Y; Bahcheli A; Diaz-Mejia JJ; Golser J; Bach K; Phuong-Bao T; Skowron P; Wang EY; Kumar SA; Balin P; Visvanathan A; Lee JJY; Ayoub R; Chen X; Chen X; Mungall KL; Luu B; Bérubé P; Wang YC; Pfister SM; Kim SK; Delattre O; Bourdeaut F; Doz F; Masliah-Planchon J; Grajkowska WA; Loukides J; Dirks P; Fèvre-Montange M; Jouvet A; French PJ; Kros JM; Zitterbart K; Bailey SD; Eberhart CG; Rao AAN; Giannini C; Olson JM; Garami M; Hauser P; Phillips JJ; Ra YS; de Torres C; Mora J; Li KKW; Ng HK; Poon WS; Pollack IF; López-Aguilar E; Gillespie GY; Van Meter TE; Shofuda T; Vibhakar R; Thompson RC; Cooper MK; Rubin JB; Kumabe T; Jung S; Lach B; Iolascon A; Ferrucci V; de Antonellis P; Zollo M; Cinalli G; Robinson S; Stearns DS; Van Meir EG; Porrati P; Finocchiaro G; Massimino M; Carlotti CG; Faria CC; Roussel MF; Boop F; Chan JA; Aldinger KA; Razavi F; Silvestri E; McLendon RE; Thompson EM; Ansari M; Garre ML; Chico F; Eguía P; Pérezpeña M; Morrissy AS; Cavalli FMG; Wu X; Daniels C; Rich JN; Jones SJM; Moore RA; Marra MA; Huang X; Reimand J; Sorensen PH; Wechsler-Reya RJ; Weiss WA; Pugh TJ; Garzia L; Kleinman CL; Stein LD; Jabado N; Malkin D; Ayrault O; Golden JA; Ellison DW; Doble B; Ramaswamy V; Werbowetski-Ogilvie TE; Suzuki H; Millen KJ; Taylor MD
    Nature; 2022 Sep; 609(7929):1021-1028. PubMed ID: 36131014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes.
    Li Z; Wei Y; Shao Y; Tang L; Gong J
    Brain Tumor Pathol; 2021 Jul; 38(3):234-242. PubMed ID: 34180021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the homeobox genes OTX2 and OTX1 in the early developing human brain.
    Larsen KB; Lutterodt MC; Møllgård K; Møller M
    J Histochem Cytochem; 2010 Jul; 58(7):669-78. PubMed ID: 20354145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells.
    Lawinger P; Venugopal R; Guo ZS; Immaneni A; Sengupta D; Lu W; Rastelli L; Marin Dias Carneiro A; Levin V; Fuller GN; Echelard Y; Majumder S
    Nat Med; 2000 Jul; 6(7):826-31. PubMed ID: 10888935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.